|
Research Management and Support - Total
|
RMS2012 [E]
|
$374,919,382
|
$284,939
|
N/A
|
(NCI)
|
|
Integration of Flexible Micro Spring Array and High Throughput Microfluidics for
|
1DP2CA174508-01
|
$2,235,000
|
$2,235,000
|
Zheng, Siyang
|
PENNSYLVANIA STATE UNIVERSITY-UNIV PARK
|
|
Immunotoxin Therapy of Solid and Hematopoietic Tumors: Preclinical Studies
|
ZIABC008753
|
$1,780,777
|
$1,780,777
|
Pastan, Ira
|
CCR (NCI)
|
|
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy
|
ZIBBC010906
|
$1,555,531
|
$1,555,531
|
Waldmann, Thomas
|
CCR (NCI)
|
|
Probing Tumor Microenvironment Using Nanotechnology
|
5R01CA126642-05
|
$1,507,967
|
$1,507,967
|
Jain, Rakesh
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Targeted Two-Photon Photodynamic Therapy Triads
|
N44CO120093-000
|
$1,499,896
|
$1,499,896
|
SPANGLER, CHARLES
|
SENSOPATH TECHNOLOGIES, INC.
|
|
Development of a Companion Diagnostic for ALK Mutations."
|
N44CO120047-000
|
$1,495,220
|
$1,495,220
|
HOUT, DAVID
|
INSIGHT GENETICS, INC.
|
|
Novel Biophotonics Methodology for Colon Cancer Screening
|
5R01CA128641-05
|
$1,489,868
|
$1,489,868
|
BACKMAN, VADIM
|
NORTHWESTERN UNIVERSITY
|
|
Growth Factor Imaging
|
ZIABC010656
|
$1,481,827
|
$444,548
|
Choyke, Peter
|
CCR (NCI)
|
|
Intraoperative Near-Infrared Fluorescence Imaging
|
5R01CA115296-08
|
$1,439,566
|
$1,439,566
|
Frangioni, John
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Prostate Cancer Imaging
|
ZIABC010655
|
$1,234,856
|
$246,971
|
Choyke, Peter
|
CCR (NCI)
|
|
Lambda Genetic Networks and Lambda Red-Mediated Recombination
|
ZIABC010336
|
$1,185,164
|
$296,291
|
Court, Donald
|
CCR (NCI)
|
|
Biomolecular Structure and Mechanism, Structure-Based Drug Design
|
ZIABC010326
|
$1,103,225
|
$1,103,225
|
Ji, Xinhua
|
CCR (NCI)
|
|
DNA Vaccines
|
ZIABC010749
|
$1,080,772
|
$54,039
|
Pavlakis, George
|
CCR (NCI)
|
|
DNA Polymerase Fidelity Mechanisms: Theory and Experiment
|
5U19CA105010-09
|
$1,030,757
|
$1,030,757
|
GOODMAN, MYRON
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
EndoPulse System for Endoscopic Ultrasound-Guided Therapy of Pancreatic Carcinoma
|
2R44CA150484-02
|
$1,019,109
|
$1,019,109
|
NUCCITELLI, RICHARD
|
BIOELECTROMED CORPORATION
|
|
Cell Prep Core
|
ZICBC010905
|
$1,011,774
|
$202,355
|
Wunderlich, John
|
CCR (NCI)
|
|
Cell Production Facility Core
|
ZICBC011020
|
$1,011,773
|
$202,355
|
Dudley, Mark
|
CCR (NCI)
|
|
Topic 287, Phase II: "Nanotechnology Sensing Platforms"
|
N44CO120043-000
|
$1,000,000
|
$1,000,000
|
CHAKRAVARTY, SWAPNAJIT
|
OMEGA OPTICS, INC.
|
|
Topic 258, Phase II: "Development of a Uni-Directional Brachytherapy Device for t
|
N44CO120052-000
|
$998,964
|
$998,964
|
PEREZ, KRISTY
|
CIVATECH ONCOLOGY, INC.
|
|
Fluorescein for Sentinel Lymph Node Detection
|
5R42CA121743-05
|
$995,474
|
$995,474
|
MCGREEVY, JAMES
|
VESTAN, INC.
|
|
Intracellular In vivo Imaging
|
ZIABC010657
|
$987,885
|
$543,337
|
Choyke, Peter
|
CCR (NCI)
|
|
Validation and commercialization of a/LCI for detection of esophageal neoplasia
|
5R44CA128163-06
|
$980,392
|
$980,392
|
Gebhart, Steven
|
ONCOSCOPE, INC.
|
|
A kit based PET agent: edotreotide Ga 68 for clinical imaging of somatostatin rec
|
2R44CA157090-02
|
$979,500
|
$979,500
|
Kronauge, James
|
MOLECULAR INSIGHT PHARMACEUTICALS, INC.
|
|
Automated Systems for Detection and Molecular Characterization of Circulating Tum
|
5R44CA122444-06
|
$979,021
|
$979,021
|
LUO, YULING
|
ADVANCED CELL DIAGNOSTICS, INC.
|
|
Rapid breath detection of lung cancer
|
N43CO110066-002
|
$971,442
|
$971,442
|
RHODES, PAUL
|
ISENSE MEDICAL CORP.
|
|
Ultrasound Ablation on Bone Cancer Under CT Fluoroscopy
|
5R44CA112852-05
|
$941,541
|
$941,541
|
Burdette, Everette
|
ACOUSTIC MEDSYSTEMS, INC.
|
|
Molecular Chaperones and DNA Replication
|
ZIABC008710
|
$926,480
|
$926,480
|
Wickner, Sue
|
CCR (NCI)
|
|
Design and Utility of Novel Proteinaceous Biomaterials
|
ZIABC011313
|
$906,711
|
$816,040
|
Schneider, Joel
|
CCR (NCI)
|
|
Search for the Structural Basis of Biomacromolecular Function and Activity
|
ZIABC010379
|
$900,806
|
$135,121
|
Wang, Yun-Xing
|
CCR (NCI)
|
|
Dedicated High-Performance Breast PET/CT
|
5R01CA129561-04
|
$884,608
|
$884,608
|
BADAWI, RAMSEY
|
UNIVERSITY OF CALIFORNIA DAVIS
|
|
Device to Improve Treatment of Colorectal CA using O2 Dependent Phosphorescence
|
2R44CA153571-02
|
$879,262
|
$879,262
|
Zand, Jason
|
SURGISENSE CORPORATION
|
|
Clinical Trials with Immunotoxins
|
ZIABC010020
|
$821,897
|
$657,518
|
Pastan, Ira
|
CCR (NCI)
|
|
Center for Interventional Oncology
|
ZIDBC011242
|
$801,130
|
$120,170
|
Wood, Bradford
|
CCR (NCI)
|
|
Low-Cost Digital Gene Expression System
|
2R44CA130275-02A1
|
$787,516
|
$787,516
|
Gordon, Steven
|
INTELLIGENT BIO-SYSTEMS, INC.
|
|
Open vs Robot-Assisted Radical Cystectomy: A Randomized Trial
|
7R01CA155388-03
|
$783,812
|
$783,812
|
PAREKH, DIPEN
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Improving the Specificity of Breast MRI Through Improved DWI
|
5R01CA154433-02
|
$760,923
|
$760,923
|
HANCU, ILEANA
|
GENERAL ELECTRIC GLOBAL RESEARCH CTR
|
|
A Nanotechnology Enabled Diagnostic Platform for Early Stage Cancer Detection
|
5R44CA143232-03
|
$749,659
|
$749,659
|
Nelson, James
|
INANOVATE, INC.
|
|
An Integrated CT-based Image-Guided Neurosurgical System
|
5R44CA112966-03
|
$738,678
|
$738,678
|
Li, Senhu
|
XORAN TECHNOLOGIES, INC.
|
|
Development of a low-cost hardware accelerator for 3D image registration
|
5R42CA137886-03
|
$736,244
|
$736,244
|
Shekhar, Raj
|
IGI TECHNOLOGIES, INC.
|
|
MRI Image Guided Radiation Therapy (IGRT) system with low cost, highly stable mag
|
5R44CA144415-03
|
$727,945
|
$727,945
|
Tomsic, Michael
|
HYPER TECH RESEARCH, INC.
|
|
Combined Digital X-Ray, Optical, and Ultrasound Breast Imaging
|
5R01CA091713-10
|
$726,385
|
$726,385
|
CARSON, PAUL
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
MR-Image Guided Focused Ultrasound for Treatment of Liver and Renal Cancer
|
5R01CA121163-07
|
$718,295
|
$718,295
|
Pauly, Kim
|
STANFORD UNIVERSITY
|
|
Breast PETX: Mammography Machine PET Scanner with Biopsy Guidance
|
1R01CA163498-01A1
|
$705,071
|
$705,071
|
MacDonald, Lawrence
|
UNIVERSITY OF WASHINGTON
|
|
Development of Recombinant Toxins to Treat Hematologic Malignancies
|
ZIABC010301
|
$698,505
|
$558,804
|
Kreitman, Robert
|
CCR (NCI)
|
|
Light Scattering and Normal Tissue Models
|
5R01CA071898-14
|
$697,307
|
$697,307
|
MOURANT, JUDITH
|
LOS ALAMOS NAT SECTY-LOS ALAMOS NAT LAB
|
|
Development of Pro-SELEX Aptamer Selection Platform
|
2R44CA150490-02A1
|
$693,881
|
$693,881
|
DEMPSEY, PAUL
|
CYNVENIO BIOSYSTEMS, INC.
|
|
Ultrasound imaging and local drug delivery in tumors
|
5R01CA103828-09
|
$688,753
|
$688,753
|
FERRARA, KATHERINE
|
UNIVERSITY OF CALIFORNIA DAVIS
|
|
A Platform for Cancer Biomarker Validation: Image Fusion Using NIR Fluorescence
|
5R01CA134493-04
|
$688,070
|
$688,070
|
Frangioni, John
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Data acquisition system for multiplex analysis of color encoded particles
|
5R42CA140109-04
|
$682,533
|
$682,533
|
Gorbovitski, Boris
|
ADVANCED BIOMEDICAL MACHINES, INC.
|
Total relevant funding to Bioengineering for this search: $155,566,995
|